Evidence map›Paper›PMID 20543850›Full record

ArticleNature chemical biology2010

Marine antifungal theonellamides target 3beta-hydroxysterol to activate Rho1 signaling.

Shinichi Nishimura, Yuko Arita, Miyuki Honda, Kunihiko Iwamoto, Akihisa Matsuyama, Atsuko Shirai, Hisashi Kawasaki, Hideaki Kakeya, Toshihide Kobayashi, Shigeki Matsunaga and 1 more

Abstract read
PubMed Publisher
In one paragraph

Article in Nature chemical biology, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 30 papers.

0numbers the graph read from it
0cells of the map it votes in
30citing papers in PubMed
7.8field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

30 citing papers in PubMed, 124 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Review
  6. Review
  7. Formation of giant ER sheets by pentadecanoic acid causes lipotoxicity in fission yeast.Proceedings of the National Academy of Sciences of the United States of America · 2025
    Article
  8. Review
  9. Review
  10. Theonellamides J and K and 5-Marine drugs · 2021
    Article
  11. Review
  12. Article
  13. Article
  14. Review
  15. Review
  16. Bicyclic Peptides as Next-Generation Therapeutics.Chemistry (Weinheim an der Bergstrasse, Germany) · 2017
    Review
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 3 institutions in 1 country.

Shinichi NishimuraChemical Genomics Research Group, RIKEN Advanced Science Institute, Saitama, Japan.
Yuko Arita
Miyuki Honda
Kunihiko Iwamoto
Akihisa Matsuyama
Atsuko Shirai
Hisashi Kawasaki
Hideaki Kakeya
Toshihide Kobayashi
Shigeki Matsunaga
Minoru Yoshida
RIKEN Advanced Science Institute · JPThe University of Tokyo · JPTokyo Denki University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Linking bioactive compounds to their cellular targets is a central challenge in chemical biology. Here we report the mode of action of theonellamides, bicyclic peptides derived from marine sponges. We generated a chemical-genomic profile of theonellamide F using a collection of fission yeast strains in which each open reading frame (ORF) is expressed under the control of an inducible promoter. Clustering analysis of the Gene Ontology (GO) terms associated with the genes that alter drug sensitivity suggested a mechanistic link between theonellamide and 1,3-beta-D-glucan synthesis. Indeed, theonellamide F induced overproduction of 1,3-beta-D-glucan in a Rho1-dependent manner. Subcellular localization and in vitro binding assays using a fluorescent theonellamide derivative revealed that theonellamides specifically bind to 3beta-hydroxysterols, including ergosterol, and cause membrane damage. The biological activity of theonellamides was alleviated in mutants defective in ergosterol biosynthesis. Theonellamides thus represent a new class of sterol-binding molecules that induce membrane damage and activate Rho1-mediated 1,3-beta-D-glucan synthesis.

Indexed as

AnimalsAntifungal AgentsDrug Evaluation, PreclinicalEchinocandinsGene Expression ProfilingHydroxysteroidsLipopeptidesMarine BiologyMicafunginMolecular StructurePeptides, Cyclicrho GTP-Binding ProteinsSchizosaccharomycesSchizosaccharomyces pombe ProteinsTheonellaAntifungal AgentsEchinocandinsHydroxysteroidsLipopeptidesMicafunginPeptides, Cyclicrho1 protein, S pomberho GTP-Binding ProteinsSchizosaccharomyces pombe Proteinstheonellamide F

Identifiers

PMID20543850
OpenAlexW2122401109

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.